Explore the full directors' dealings record of 泓博医药, a publicly traded company based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €4.2bn. The latest transaction was filed on 30 December 2025 — Sale. Among the most active insiders: 泓博智源(香港)医药技术有限公司. All data is free.